Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × inavolisib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 1 PIK3CA-Mutated Cancers 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Metastatic Castration-Resistant Prostate Cancer 1 HER2-positive Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 274 Paclitaxel 273 Bevacizumab 148 liposomal doxorubicin 86 pembrolizumab 84 Gemcitabine 82 Cyclophosphamide 81 olaparib 79 Cisplatin 75 Topotecan 72 niraparib 59 Docetaxel 49 Doxorubicin 44 Drug Therapy 38 fludarabine 35 Taxes 35 Nivolumab 32 Filgrastim 31 Specimen Handling 29 Etoposide 28 Surveys and Questionnaires 27 Magnetic Resonance Spectroscopy 27 Hyperthermic Intraperitoneal Chemotherapy 27 Peripheral Blood Stem Cell Transplantation 23 durvalumab 21 Immunoglobulin G 21 Disulfides 21 Cytoreduction Surgical Procedures 21 Blood Specimen Collection 21 Biopsy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04931342 2026-03-10

BOUQUET

Hoffmann-La Roche

Phase 2 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡